第八章 參考文獻
1. Abdi, R., Tran, T. B., Zee, R., Brenner, B. M., & Milford, E. L. (2001). Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation, 72(4), 726-729.
2.Abdollahi, M. R., Lewis, R. M., Gaunt, T. R., Cumming, D. V., Rodriguez, S., Rose-Zerilli, M., Collins, A. R., Syddall, H. E., Howell, W. M., Cooper, C., et al. (2007). Quantitated transcript haplotypes (QTH) of AGTR1, reduced abundance of mRNA haplotypes containing 1166C (rs5186:A>C), and relevance to metabolic syndrome traits. Hum Mutat, 28(4), 365-373.
3.Amin, R., Turner, C., van Aken, S., Bahu, T. K., Watts, A., Lindsell, D. R., Dalton, R. N., & Dunger, D. B. (2005). The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int, 68(4), 1740-1749.
4.Anbazhagan, K., Sampathkumar, K., Ramakrishnan, M., Gomathi, P., Gomathi, S., & Selvam, G. S. (2009). Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients. Clin Chim Acta, 406(1-2), 108-112.
5.Appel, G. B., & Appel, A. S. (2004). Angiotensin II receptor antagonists: role in hypertension, cardiovascular disease, and renoprotection. Prog Cardiovasc Dis, 47(2), 105-115.
6.Baggio, B., Budakovic, A., Dalla Vestra, M., Saller, A., Bruseghin, M., & Fioretto, P. (2002). Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol, 13(11), 2730-2736.
7.Balakrishnan, V. S., Jaber, B. L., Natov, S. N., Cendoroglo, M., King, A. J., Schmid, C. H., & Pereira, B. J. (1998). Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients. Kidney Int, 54(6), 2106-2112.
8.Bonnardeaux, A., Davies, E., Jeunemaitre, X., Fery, I., Charru, A., Clauser, E., Tiret, L., Cambien, F., Corvol, P., & Soubrier, F. (1994). Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension, 24(1), 63-69.
9.Bowden, D. W. (2003). Genetics of kidney disease. Kidney Int Suppl(83), S8-12.
10.Buraczynska, M., Ksiazek, P., Drop, A., Zaluska, W., Spasiewicz, D., & Ksiazek, A. (2006). Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant, 21(4), 979-983.
11.Burgess, E. (1999). Conservative treatment to slow deterioration of renal function: evidence-based recommendations. Kidney Int Suppl, 70, S17-25.
12.Chan, L. Y., Leung, J. C., Tang, S. C., Choy, C. B., & Lai, K. N. (2005). Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol, 16(8), 2306-2317.
13.Chang, S. N., Lin, J. W., Juang, J. M., Tsai, C. T., Hwang, J. J., & Chiang, F. T. (2010). Association between genetic polymorphisms in the renin-angiotensin system and systolic heart failure revised by a propensity score-based analysis. Cardiology, 116(4), 279-285.
14.Chaves, F. J., Corella, D., Sorli, J. V., Marin-Garcia, P., Guillen, M., & Redon, J. (2004). Polymorphisms of the renin-angiotensin system influence height in normotensive women in a Spanish population. J Clin Endocrinol Metab, 89(5), 2301-2305.
15.Chen, J., Chen, J. K., Neilson, E. G., & Harris, R. C. (2006). Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy. J Am Soc Nephrol, 17(6), 1615-1623.
16.Chen, Y., Lasaitiene, D., & Friberg, P. (2004). The renin-angiotensin system in kidney development. Acta Physiol Scand, 181(4), 529-535.
17.Cosentino, F., Savoia, C., De Paolis, P., Francia, P., Russo, A., Maffei, A., Venturelli, V., Schiavoni, M., Lembo, G., & Volpe, M. (2005). Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens, 18(4 Pt 1), 493-499.
18.Davis, J. O., Hartroft, P. M., Titus, E. O., Carpenter, C. C., Ayers, C. R., & Spiegel, H. E. (1962). The role of the renin-angiotensin system in the control of aldosterone secretion. J Clin Invest, 41, 378-389.
19.De Paolis, P., Porcellini, A., Savoia, C., Lombardi, A., Gigante, B., Frati, G., Rubattu, S., Musumeci, B., & Volpe, M. (2002). Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. J Hypertens, 20(4), 693-699.
20.Dzau, V. J. (1998). Mechanism of protective effects of ACE inhibition on coronary artery disease. Eur Heart J, 19 Suppl J, J2-6.
21.Erdos, E. G. (1976). Conversion of angiotensin I to angiotensin II. Am J Med, 60(6), 749-759.
22.Eriksen, B. O., & Ingebretsen, O. C. (2006). The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int, 69(2), 375-382.
23.Ewert, S., Sjoberg, T., Johansson, B., Duvetorp, A., Holm, M., & Fandriks, L. (2006). Dynamic expression of the angiotensin II type 2 receptor and duodenal mucosal alkaline secretion in the Sprague-Dawley rat. Exp Physiol, 91(1), 191-199.
24.Ewert, S., Spak, E., Olbers, T., Johnsson, E., Edebo, A., & Fandriks, L. (2006). Angiotensin II induced contraction of rat and human small intestinal wall musculature in vitro. Acta Physiol (Oxf), 188(1), 33-40.
25.Fernandez-Llama, P., Poch, E., Oriola, J., Botey, A., Rivera, F., & Revert, L. (1998). Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage. Am J Hypertens, 11(4 Pt 1), 439-444.
26.Fogo, A. B. (2000). Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney Int Suppl, 75, S15-21.
27.Fox, C. S., Larson, M. G., Leip, E. P., Culleton, B., Wilson, P. W., & Levy, D. (2004). Predictors of new-onset kidney disease in a community-based population. JAMA, 291(7), 844-850.
28.Frimat, L., Philippe, C., Maghakian, M. N., Jonveaux, P., Hurault de Ligny, B., Guillemin, F., & Kessler, M. (2000). Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men. J Am Soc Nephrol, 11(11), 2062-2067.
29.Gardemann, A., Stricker, J., Humme, J., Nguyen, Q. D., Katz, N., Philipp, M., Tillmanns, H., Hehrlein, F. W., & Haberbosch, W. (1999). Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis, 145(2), 309-314.
30.Gigante, B., Piras, O., Savoia, C., De Paolis, P., Rubattu, S., Panina, G., & Volpe, M. (2000). Role of angiotensin II AT1 and AT2 subtype receptors in the regulation of atrial natriuretic peptide expression in salt-restricted rats. Basic Res Cardiol, 95(1), 64-69.
31.Girndt, M., Ulrich, C., Kaul, H., Sester, U., Sester, M., & Kohler, H. (2003). Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int Suppl(84), S76-79.
32.Goldbergova, M., Spinarova, L., Spinar, J., Toman, J., Vasku, A., & Vacha, J. (2003). Association of two angiotensinogen gene polymorphisms, M235T and G(-6)A, with chronic heart failure. Int J Cardiol, 89(2-3), 267-272.
33.Gonzalez, M., Lobos, L., Castillo, F., Galleguillos, L., Lopez, N. C., & Michea, L. (2005). High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries. Hypertension, 45(5), 853-859.
34.Hayashi, K., Miyamoto, A., Berisha, B., Kosmann, M. R., Okuda, K., & Schams, D. (2000). Regulation of angiotensin II production and angiotensin receptors in microvascular endothelial cells from bovine corpus luteum. Biol Reprod, 62(1), 162-167.
35.Henkin, L., Bergman, R. N., Bowden, D. W., Ellsworth, D. L., Haffner, S. M., Langefeld, C. D., Mitchell, B. D., Norris, J. M., Rewers, M., Saad, M. F., et al. (2003). Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol, 13(4), 211-217.
36.Heron, M., Hoyert, D. L., Murphy, S. L., Xu, J., Kochanek, K. D., & Tejada-Vera, B. (2009). Deaths: final data for 2006. Natl Vital Stat Rep, 57(14), 1-134.
37.Himmelfarb, J. (2007). Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA, 297(23), 2630-2633.
38.Hunley, T. E., Julian, B. A., Phillips, J. A., 3rd, Summar, M. L., Yoshida, H., Horn, R. G., Brown, N. J., Fogo, A., Ichikawa, I., & Kon, V. (1996). Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int, 49(2), 571-577.
39.Hwang, S. J., Tsai, J. C., & Chen, H. C. (2010). Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton), 15 Suppl 2, 3-9.
40.Ise, K., Sato, Y., Matsuyama, S., Gunji, T., Ishii, S., Yamashita, M., Kanazawa, Y., & Gotoh, M. (2004). Transforming growth factor-beta signaling is enhanced following mitomycin-C treatment of islet xenograft. Transplant Proc, 36(4), 1183-1185.
41.Iseki, K. (2003). The okinawa screening program. J Am Soc Nephrol, 14(7 Suppl 2), S127-130.
42.Israni, A. K., Li, N., Sidhwani, S., Rosas, S., Kong, X., Joffe, M., Rebbeck, T., & Feldman, H. I. (2007). Association of hypertension genotypes and decline in renal function after kidney transplantation. Transplantation, 84(10), 1240-1247.
43.Ito, M., Oliverio, M. I., Mannon, P. J., Best, C. F., Maeda, N., Smithies, O., & Coffman, T. M. (1995). Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A, 92(8), 3521-3525.
44.Jugdutt, B. I., Xu, Y., Balghith, M., Moudgil, R., & Menon, V. (2000). Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: association with regional increase in AT2R, IP3R and PKCepsilon proteins and cGMP. J Cardiovasc Pharmacol Ther, 5(4), 301-311.
45.Lai, K. N., Chan, L. Y., Tang, S. C., Tsang, A. W., Li, F. F., Lam, M. F., Lui, S. L., & Leung, J. C. (2004). Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int, 66(4), 1403-1416.
46.Liu, K. P., Lin, C. Y., Chen, H. J., Wei, C. F., & Lee-Chen, G. J. (2004). Renin-angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux. Pediatr Nephrol, 19(6), 594-601.
47.Locatelli, F., Marcelli, D., Comelli, M., Alberti, D., Graziani, G., Buccianti, G., Redaelli, B., & Giangrande, A. (1996). Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. Nephrol Dial Transplant, 11(3), 461-467.
48.Losito, A., Kalidas, K., Santoni, S., & Jeffery, S. (2003). Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int, 64(2), 616-622.
49.Lovati, E., Richard, A., Frey, B. M., Frey, F. J., & Ferrari, P. (2001). Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int, 60(1), 46-54.
50.Lysaght, M. J. (2002). Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol, 13 Suppl 1, S37-40.
51.Ma, Y. C., Zuo, L., Chen, J. H., Luo, Q., Yu, X. Q., Li, Y., Xu, J. S., Huang, S. M., Wang, L. N., Huang, W., et al. (2007). Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int, 72(12), 1535-1542.
52.Mazzocchi, G., Malendowicz, L. K., Markowska, A., Albertin, G., & Nussdorfer, G. G. (2000). Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats. Am J Physiol Endocrinol Metab, 278(6), E1027-1030.
53.Meguid El Nahas, A., & Bello, A. K. (2005). Chronic kidney disease: the global challenge. Lancet, 365(9456), 331-340.
54.Miners, S., Ashby, E., Baig, S., Harrison, R., Tayler, H., Speedy, E., Prince, J. A., Love, S., & Kehoe, P. G. (2009). Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res, 1(2), 163-177.
55.Nishikino, M., Matsunaga, T., Yasuda, K., Adachi, T., Moritani, T., Tsujimoto, G., Tsuda, K., & Aoki, N. (2006). Genetic variation in the renin-angiotensin system and autonomic nervous system function in young healthy Japanese subjects. J Clin Endocrinol Metab, 91(11), 4676-4681.
56.Niu, T., Yang, J., Wang, B., Chen, W., Wang, Z., Laird, N., Wei, E., Fang, Z., Lindpaintner, K., Rogus, J. J., et al. (1999). Angiotensinogen gene polymorphisms M235T/T174M: no excess transmission to hypertensive Chinese. Hypertension, 33(2), 698-702.
57.Niu, W., Qi, Y., Gao, P., & Zhu, D. (2010). Association between angiotensin converting enzyme G2350A polymorphism and hypertension risk: a meta-analysis. J Renin Angiotensin Aldosterone Syst.
58.Niu, W., Qi, Y., Hou, S., Zhai, X., Zhou, W., & Qiu, C. (2009). Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens, 27(7), 1384-1391.
59.NKF. eGFR. National Kidney Foundation.
60.Nomura, I., Kato, J., & Kitamura, K. (2009). Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community. Vasc Health Risk Manag, 5(1), 315-320.
61.Note on the 2007-2008 Data Documentation. (2011). CDC,NHANES 2007-2008.
62.Oda, N., Minoguchi, K., Yokoe, T., Hashimoto, T., Wada, K., Miyamoto, M., Tanaka, A., Kohno, Y., & Adachi, M. (1999). Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Life Sci, 65(8), 763-770.
63.Oda, N., Takeda, Y., Zhu, A., Usukura, M., Yoneda, T., Takata, H., & Mabuchi, H. (2006). Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism. Hypertens Res, 29(1), 9-14.
64.Oishi, Y., Ozono, R., Yoshizumi, M., Akishita, M., Horiuchi, M., & Oshima, T. (2006). AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling. Life Sci, 80(1), 82-88.
65.Okada, H., Inoue, T., Kikuta, T., Watanabe, Y., Kanno, Y., Ban, S., Sugaya, T., Horiuchi, M., & Suzuki, H. (2006). A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am J Pathol, 169(5), 1577-1589.
66.Okada, H., Watanabe, Y., Inoue, T., Kobayashi, T., Kikuta, T., Kanno, Y., Ban, S., & Suzuki, H. (2004). Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor. Biochem Biophys Res Commun, 314(2), 403-408.
67.Orth, S. R. (2002). Smoking and the kidney. J Am Soc Nephrol, 13(6), 1663-1672.
68.Orth, S. R., Schroeder, T., Ritz, E., & Ferrari, P. (2005). Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant, 20(11), 2414-2419.
69.Park, S. K., & Kang, S. K. (1995). Renal function and hemodynamic study in obese Zucker rats. Korean J Intern Med, 10(1), 48-53.
70.Pei, Y., Scholey, J., Thai, K., Suzuki, M., & Cattran, D. (1997). Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest, 100(4), 814-820.
71.Prasad, P., Tiwari, A. K., Kumar, K. M., Ammini, A. C., Gupta, A., Gupta, R., Sharma, A. K., Rao, A. R., Nagendra, R., Chandra, T. S., et al. (2006). Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet, 7, 42.
72.Ran, J., Hirano, T., & Adachi, M. (2005). Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats. J Hypertens, 23(8), 1525-1530.
73.Regitz-Zagrosek, V., Neuss, M., Holzmeister, J., Warnecke, C., & Fleck, E. (1996). Molecular biology of angiotensin receptors and their role in human cardiovascular disease. J Mol Med, 74(5), 233-251.
74.Reis, K., Arinsoy, T., Derici, U., Gonen, S., Bicik, Z., Soylemezoglu, O., Yasavul, U., Hasanoglu, E., & Sindel, S. (2005). Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction. Clin Transplant, 19(1), 10-14.
75.Ruiz-Ortega, M., Ruperez, M., Lorenzo, O., Esteban, V., Blanco, J., Mezzano, S., & Egido, J. (2002). Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl(82), S12-22.
76.Saidi, S., Mallat, S. G., Almawi, W. Y., & Mahjoub, T. (2009). Association between renin-angiotensin-aldosterone system genotypes and haplotypes and risk of ischemic stroke of atherosclerotic etiology. Acta Neurol Scand, 119(6), 356-363.
77.Sakharova, O. V., Taal, M. W., & Brenner, B. M. (2001). Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor. Curr Opin Nephrol Hypertens, 10(6), 727-738.
78.Sato, N., Katsuya, T., Rakugi, H., Takami, S., Nakata, Y., Miki, T., Higaki, J., & Ogihara, T. (1997). Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension, 30(3 Pt 1), 321-325.
79.Saucier, N. A., Sinha, M. K., Liang, K. V., Krambeck, A. E., Weaver, A. L., Bergstralh, E. J., Li, X., Rule, A. D., & Lieske, J. C. (2010). Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis, 55(1), 61-68.
80.Schmidt, S., Giessel, R., Bergis, K. H., Strojek, K., Grzeszczak, W., Ganten, D., & Ritz, E. (1996). Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant, 11(9), 1755-1761.
81.Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989). Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med, 320(18), 1161-1165.
82.System., U. S. R. D. (2009). United States Renal Data System.
83.Taal, M. W., & Brenner, B. M. (2006). Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int, 70(10), 1694-1705.
84.van Ittersum, F. J., de Man, A. M., Thijssen, S., de Knijff, P., Slagboom, E., Smulders, Y., Tarnow, L., Donker, A. J., Bilo, H. J., & Stehouwer, C. D. (2000). Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant, 15(7), 1000-1007.
85.Vasku, A., Soucek, M., Tschoplova, S., & Stejskalova, A. (2002). An association of BMI with A (-6) G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension. J Hum Hypertens, 16(6), 427-430.
86.Wen, C. P., Cheng, T. Y., Tsai, M. K., Chang, Y. C., Chan, H. T., Tsai, S. P., Chiang, P. H., Hsu, C. C., Sung, P. K., Hsu, Y. H., et al. (2008). All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet, 371(9631), 2173-2182.
87.Wong, C., Kanetsky, P., & Raj, D. (2008). Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatr Nephrol, 23(7), 1037-1051.
88.Woo, K. T., Lau, Y. K., Choong, L. H., Zhao, Y., Tan, H. B., Fook-Chong, S., Tan, E. K., Yap, H. K., & Wong, K. S. (2004). Polymorphism of renin-angiotensin system genes in IgA nephropathy. Nephrology (Carlton), 9(5), 304-309.
89.Wu, C. K., Tsai, C. T., Hwang, J. J., Luo, J. L., Juang, J. J., Hsu, K. L., Lai, L. P., Lin, J. L., Tseng, C. D., & Chiang, F. T. (2008). Renin-angiotensin system gene polymorphisms and diastolic heart failure. Eur J Clin Invest, 38(11), 789-797.
90.Yuan, J., Tang, W., Chun, Y., Ying, H., Yang, Y., & Xiao, C. (2009). Angiotensinogen T174M and M235T variants and hypertension in the Hani and Yi minority groups of China. Biochem Genet, 47(5-6), 344-350.
91.Zhang, X., Erdmann, J., Regitz-Zagrosek, V., Kurzinger, S., Hense, H. W., & Schunkert, H. (2000). Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene. J Hypertens, 18(3), 267-272.
92.Zhao, Y. Y., Zhou, J., Narayanan, C. S., Cui, Y., & Kumar, A. (1999). Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension, 33(1), 108-115.
93.Zhu, X., Bouzekri, N., Southam, L., Cooper, R. S., Adeyemo, A., McKenzie, C. A., Luke, A., Chen, G., Elston, R. C., & Ward, R. (2001). Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet, 68(5), 1139-1148.
94.王舒民, 楊., 黃秋錦. (2008). 慢性腎臟病與高血壓. 腎臟與透析, 19(2).95.江守山. (2008). 台灣洗腎有保障 日本、歐美追不上. from http://blog.sina.com.tw/little/article.php?pbgid=41946&entryid=580701
96.行政院衛生署國民健康局. (2010). 2007年台灣地區高血壓高血糖高血脂之追蹤調查研究. 行政院衛生署國民健康局.
97.行政院衛生署國民健康局. (2010). 死因統計表.
98.周先樂. (2000.). 人體生理學. 藝軒圖書出版社.
99.周先樂. ( 2000). 人體生理學, 藝軒圖書出版社.
100.秦亞惠. (2005). Angiotensin-Converting Enzyme Inhibitor(ACEI)與 Angiotensin Receptor Blocker(ARB)臨床應用之差異. 三總藥訊.
101.張文華. (2006). HbA1c-糖化血色素( glycated hemoglobin). from http://health.wedar.com/show.asp?id=824
102.陳瑞祈, 陳., 陳秋月,周明謹,麥秀琴,黃麗利,李素珠,張哲銘. (2010). 慢性腎臟並完整照護計畫介入可延緩腎功能惡化. 台灣腎臟戶喜學會雜誌, 9(2), 34-39.
103.曾慶孝. 老化與糖尿病. from http://www.alum.ntu.edu.tw/print.php?num=43&sn=915&check=
104.腎臟指標. 台灣腎臟醫學會.
105.黃尚志. (2007). 慢性腎臟病防治手冊: 行政院衛生署國民健康局.
106.黃尚志. (2009). 台灣慢性腎臟病流行病學與防治醫療網. 高雄醫學大學.
107.衛生署98年死因統計. (2009). 衛生署.